Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet.
The proband was born at 36 weeks, appropriate for gestational age, to nonconsanguineous white parents. There was no evidence of hyperbilirubinemia or intrahepatic cholestasis in the neonatal period, and she had normal newborn screen results. She presented with 3 episodes of life-threatening bleeding and anemia. The diagnostic evaluation for her bleeding diathesis revealed an abnormal clotting profile with no biochemical evidence for hepatocellular damage. She was incidentally noted to have severe growth deceleration that failed to respond to 502 kJ/kg (120 kcal/kg) per day of protein-hydrolyzed formula. An extensive diagnostic workup for failure to thrive, which was otherwise normal, included plasma amino acid analysis that revealed hyperglutaminemia and citrulline levels within the reference range. Testing of a repeat sample revealed isolated hypercitrullinemia. No argininosuccinic acid was detected. Her ammonia level and urine orotic acid were within the reference ranges. Subsequent plasma amino acid analysis exhibited a profile suggestive of neonatal intrahepatic cholestasis caused by citrin deficiency with elevations in citrulline, methionine, and threonine. Western blotting of fibroblasts demonstrated citrin deficiency, and a deletion for exon 3 was found in the patient's coding DNA of the SLC25A13 gene. On the basis of the experience with adults carrying this condition, the patient was given a high-protein, low-carbohydrate diet. The failure to thrive and bleeding diathesis resolved. When compliance with the dietary prescription was relaxed, growth deceleration was again noted, although significant bleeding did not recur. This is the first report of an infant of Northern European descent with citrin deficiency. The later age at presentation with failure to thrive and bleeding diathesis and without obvious evidence of neonatal intrahepatic cholestasis expands the clinical spectrum of citrin deficiency. This case emphasizes the importance of continued dietary control and growth monitoring in children with neonatal intrahepatic cholestasis caused by citrin deficiency and identifies a new metabolic entity responsible for failure to thrive.
Dimmock
David
D
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Kobayashi
Keiko
K
Iijima
Mikio
M
Tabata
Ayako
A
Wong
Lee-Jun
LJ
Saheki
Takeyori
T
Lee
Brendan
B
Scaglia
Fernando
F
D002135:Calcium-Binding Proteins / Q000172:deficiency*; D002956:Citrulline / Q000097:blood; D050528:Diet, Carbohydrate-Restricted / Q000379:methods*; D004044:Dietary Proteins / Q000627:therapeutic use*; D005183:Failure to Thrive / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D005260:Female; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008661:Metabolism, Inborn Errors / Q000097:blood / Q000150:complications* / Q000175:diagnosis / Q000178:diet therapy*; D027361:Organic Anion Transporters / Q000172:deficiency*; D016896:Treatment Outcome
D002135:Calcium-Binding Proteins; D004044:Dietary Proteins; D027361:Organic Anion Transporters; C008822:citrin; D002956:Citrulline